ACHV READ THE FULL ACHV RESEARCH REPORT Achieve Life Sciences, Inc. (NASDAQ:ACHV) reported 2024 results sharing progress with ...

After a frustrating first day of NFL free agency, the Atlanta Falcons started making moves in the latter part of the legal tampering period by reportedly landing former Georgia star edge rusher ...

Galcanezumab provided greater reductions in migraine frequency, resulting in a shift from chronic to episodic migraine over a 12-month period compared with placebo.

The communications department will continue to deploy the project in underserviced areas, with support from Broadband Infraco ...

Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between -6.5 and -2.5, baseline slow vital capacity > 60%, and symptom ...

Unless there is a clear plan, agreed upon by both warring parties and has the endorsement of major regional stakeholders as ...

Completed enrollment of Phase 2 clinical trial of verekitug in patients with chronic rhinosinusitis with nasal polyps; top-line data expected ...

Unique Assembly, the company behind Edinburgh’s renowned Christmas markets, has submitted an application to the City of ...

Sandeep Nayak, CEO of Centrum Broking, states that the Indian stock market is recovering, with the Nifty 50 potentially ...

Company generated quarterly sequential growth in YCANTH® dispensed applicator units of 12.3% in Q4’24 concurrent with significantly lower ...

Investors currently support XRP by investing in MUTM at its phase three launch and its current price of $0.02. Investors paid ...

Discover the real physical and emotional changes men experience during prostate cancer surgery recovery - from urinary ...